INmune Bio, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue000050K000
Cost of Goods Sold52K56K000000
Gross Profit-52K-56K0050K000
R&D Expenses3.6M2.3M4.9M5.8M7.6M7.4M10.1M7.1M
Operating Expenses5.8M5.4M7.4M24.6M10.0M9.5M12.3M9.9M
Operating Income-5.8M-5.5M-7.4M-24.6M-9.9M-9.5M-12.3M-9.9M
Other Income / Gains405K210K961K113K166K249K193K119K
Net Income-5.4M-5.3M-6.5M-24.5M-9.7M-9.2M-12.1M-9.7M
EPS (Diluted)-0.20-0.20-0.24-1.05-0.43-0.41-0.60-0.50
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio00001.00000
General And Administrative Expenses2.2M3.1M2.5M2.2M2.3M2.0M2.2M2.8M
Selling And Marketing Expenses00134K55K041K40K41K
Selling General And Administrative Expenses2.2M3.1M2.7M2.3M2.3M2.0M2.3M2.8M
Other Expenses-52K-56K-134K16.5M0120K-40K0
Cost And Expenses5.8M5.5M7.4M24.6M10.0M9.5M12.3M9.9M
Interest Income0210K000000
Interest Expense00000000
Depreciation And Amortization52K56K000009.9M
Ebitda-5.4M-5.2M-6.5M-8.1M-9.7M-9.2M-12.1M119K
Ebitdaratio0000-194.78000
Operating Income Ratio0000-198.10000
Income Before Tax-5.4M-5.3M-6.5M-24.5M-9.7M-9.2M-12.1M-9.7M
Income Before Tax Ratio0000-194.78000
Income Tax Expense00000000
Net Income Ratio0000-194.78000
Epsdiluted-0.20-0.20-0.24-1.05-0.43-0.41-0.60-0.50
Weighted Average Shs Out26.6M26.6M26.6M23.3M22.5M22.3M20.2M19.3M
Weighted Average Shs Out Dil26.6M26.6M26.6M23.3M22.5M22.3M20.2M19.3M